By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Shire Pharmaceuticals Group plc 

Hampshire International Business Park
Chineham
Basingstoke  Hampshire  RG24 8EP  United Kingdom
Phone: 44-1256-894-000 Fax: 44-1256-894-708


SEARCH JOBS


Industry
Pharmaceutical






Company News
FDA Acknowledges Receipt Of Resubmission Of Shire (SHPG)'s New Drug Application For Lifitegrast For Dry Eye Disease In Adults 2/5/2016 6:14:40 AM
Shire (SHPG) Assigned Investment Grade Credit Ratings By Moody's And S&P 1/28/2016 10:49:56 AM
Shire (SHPG) Remains Tight-Lipped on Status of Facilities, Employees Inherited from Newly-Acquired Dyax (DYAX) 1/26/2016 6:51:31 AM
Shire (SHPG) Resubmits New Drug Application For Lifitegrast To U.S. FDA 1/25/2016 6:05:10 AM
Shire (SHPG) Completes Acquisition Of Dyax (DYAX) 1/22/2016 8:03:56 AM
Lucerne Biosciences Completes Sourcing Investigation Into Shire (SHPG)'s IPR That Led To The Invalidation Of The '813 Patent 1/15/2016 6:17:44 AM
Baxalta (BXLT)'s CEO Hantson to Leave After Merger With Shire (SHPG) is Complete 1/12/2016 2:51:19 PM
Lucerne Biosciences Completes Sourcing Investigation Into Shire (SHPG)'s IPR That Led To The Invalidation Of The '813 Patent; Begins Accelerated Multi-Party Public Expansion Phase Of Its Counter-Intelligence Technology 1/12/2016 6:37:34 AM
After a 6-Month Courtship, Baxalta (BXLT) Finally Says Yes to $32 Billion Shire (SHPG) Marriage Proposal 1/11/2016 6:23:13 AM
Shire (SHPG) Rumored to Announce $32.5 Billion Merger as Early as Monday, Deal Hinges on Baxalta (BXLT) Tax Status 1/8/2016 6:21:26 AM
12345678910...
//-->